Hodgkin Lymphoma

Showing NaN - NaN of 8

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Hodgkin Lymphoma, Stage I Adult Hodgkin Lymphoma, Stage II Adult Hodgkin Lymphoma Trial in Rochester (drug, genetic, other)

Withdrawn
  • Hodgkin Lymphoma
  • +4 more
  • Rochester, Minnesota
    Mayo Clinic
Nov 28, 2022

Participated in Children's Oncology Group Studies

Recruiting
  • Acute Lymphoblastic Leukemia
  • +5 more
  • Assessment of Therapy Complications
  • Questionnaire Administration
  • Birmingham, Alabama
  • +163 more
Sep 6, 2022

Commercially Available Vaccines Against SARS-CoV-2 in

Recruiting
  • Monoclonal B-Cell Lymphocytosis
  • +3 more
    • Rochester, Minnesota
      Mayo Clinic
    Feb 10, 2022

    Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Burkitt's Lymphoma Trial in United States (Haploidentical Bone Marrow

    Completed
    • Acute Lymphocytic Leukemia
    • +6 more
    • Haploidentical Bone Marrow Transplant
    • Double Umbilical Cord Blood Transplant
    • Birmingham, Alabama
    • +38 more
    Nov 2, 2021

    Hodgkin Lymphoma Trial in United States (brentuximab vedotin, nivolumab)

    Completed
    • Hodgkin Lymphoma
    • Duarte, California
    • +12 more
    Nov 3, 2021

    Hodgkin Lymphoma Trial in United States (PLX3397)

    Completed
    • Hodgkin Lymphoma
    • Los Angeles, California
    • +5 more
    Jun 18, 2020

    Hodgkin Lymphoma Trial in United States (Everolimus (RAD001))

    Completed
    • Hodgkin Lymphoma
    • Everolimus (RAD001)
    • Los Angeles, California
    • +15 more
    Apr 18, 2016

    Hodgkin Lymphoma, Mantle Cell Lymphoma, Indolent Lymphoma Trial in Canada, United States (SB1518)

    Completed
    • Hodgkin Lymphoma
    • +2 more
    • Omaha, Nebraska
    • +4 more
    Apr 19, 2012